AR054583A1 - Pantoprazol isotopicamente sustituido - Google Patents

Pantoprazol isotopicamente sustituido

Info

Publication number
AR054583A1
AR054583A1 ARP060103223A ARP060103223A AR054583A1 AR 054583 A1 AR054583 A1 AR 054583A1 AR P060103223 A ARP060103223 A AR P060103223A AR P060103223 A ARP060103223 A AR P060103223A AR 054583 A1 AR054583 A1 AR 054583A1
Authority
AR
Argentina
Prior art keywords
replaced
pantoprazol
isotopically
compounds
solvates
Prior art date
Application number
ARP060103223A
Other languages
English (en)
Spanish (es)
Inventor
Bernhard Kohl
Bernd Muller
Dieter Haag
Wolfgang-Alexander Simon
Karl Zech
Michael David
Richter Oliver Von
Felix Huth
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of AR054583A1 publication Critical patent/AR054583A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/69Two or more oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
ARP060103223A 2005-07-26 2006-07-26 Pantoprazol isotopicamente sustituido AR054583A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05106874 2005-07-26

Publications (1)

Publication Number Publication Date
AR054583A1 true AR054583A1 (es) 2007-06-27

Family

ID=35708921

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060103223A AR054583A1 (es) 2005-07-26 2006-07-26 Pantoprazol isotopicamente sustituido

Country Status (8)

Country Link
EP (1) EP1912947A1 (fr)
JP (1) JP5289951B2 (fr)
CN (1) CN101268050B (fr)
AR (1) AR054583A1 (fr)
AU (1) AU2006274037B2 (fr)
CA (1) CA2615678C (fr)
TW (1) TWI410409B (fr)
WO (1) WO2007012651A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101358509B1 (ko) * 2005-07-26 2014-02-05 다케다 게엠베하 동위 원소 치환된 양성자 펌프 억제제
US7598273B2 (en) 2005-10-06 2009-10-06 Auspex Pharmaceuticals, Inc Inhibitors of the gastric H+, K+-ATPase with enhanced therapeutic properties
EP2099299A4 (fr) * 2006-10-23 2011-11-30 Concert Pharmaceuticals Inc Dérivés d'oxazolidinone et leurs procédés d'utilisation
EP2139877B1 (fr) * 2007-03-07 2011-05-11 Concert Pharmaceuticals Inc. Dérivés de pipérazine deutérés utilisés en tant que composés antiangoreux
EP2152709B1 (fr) * 2007-05-01 2012-02-22 Concert Pharmaceuticals Inc. Composés de morphinane
ES2577477T3 (es) 2007-05-01 2016-07-15 Concert Pharmaceuticals Inc. Compuestos morfinanos
AU2008266124A1 (en) * 2007-06-13 2008-12-24 Auspex Pharmaceuticals, Inc. Substituted piperazines
US7855204B2 (en) * 2008-01-22 2010-12-21 Concert Pharmaceuticals Inc. Derivatives of gefitinib
JP5770997B2 (ja) * 2009-12-09 2015-08-26 大塚製薬株式会社 Cyp3a4の代謝機能測定方法
CN103349655B (zh) * 2013-07-22 2015-04-29 南通广泰生化制品有限公司 枸橼酸他莫昔芬肠溶胶囊
MX2017002750A (es) * 2014-09-02 2017-08-02 Singh Bhupinder Metodo para marcar una molecula deuterada o no deuterada y formulaciones farmaceuticas para tratamiento.
GB2560750A (en) * 2017-03-24 2018-09-26 Taher Darreh Shori Biological methods

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
ZA854287B (en) * 1984-06-16 1986-02-26 Byk Gulden Lomberg Chem Fab Dialkoxypyridines,process for their preparation,their use and medicaments containing them
US6334997B1 (en) * 1994-03-25 2002-01-01 Isotechnika, Inc. Method of using deuterated calcium channel blockers
WO1995026325A2 (fr) * 1994-03-25 1995-10-05 Isotechnika Inc. Potentialisation de medicaments par deuteration_______________
US6884429B2 (en) * 1997-09-05 2005-04-26 Isotechnika International Inc. Medical devices incorporating deuterated rapamycin for controlled delivery thereof
NO309305B1 (no) * 1999-02-19 2001-01-15 Norsk Hydro As Anvendelse av benzaldehydderivater ved fremstilling av farmasöytiske preparater for forebygging og/eller behandling av kreft, samt visse nye benzaldehydderivater
DE10123129A1 (de) * 2001-05-02 2002-11-14 Berolina Drug Dev Ab Svedala Deuterierte 3-Piperidinopropiophenone sowie diese Verbindungen enthaltende Arzneimittel
DE10162121A1 (de) * 2001-12-12 2003-06-18 Berolina Drug Dev Ab Svedala Deuterierte substituierte Pyrazolyl-Benzolsulfonamide sowie diese Verbindungen enthaltende Arzneimittel
KR101358509B1 (ko) * 2005-07-26 2014-02-05 다케다 게엠베하 동위 원소 치환된 양성자 펌프 억제제

Also Published As

Publication number Publication date
TW200745039A (en) 2007-12-16
EP1912947A1 (fr) 2008-04-23
CA2615678A1 (fr) 2007-02-01
CA2615678C (fr) 2015-01-20
AU2006274037A1 (en) 2007-02-01
TWI410409B (zh) 2013-10-01
JP2009502872A (ja) 2009-01-29
JP5289951B2 (ja) 2013-09-11
AU2006274037B2 (en) 2012-04-26
WO2007012651A1 (fr) 2007-02-01
CN101268050B (zh) 2012-11-28
CN101268050A (zh) 2008-09-17

Similar Documents

Publication Publication Date Title
AR054583A1 (es) Pantoprazol isotopicamente sustituido
ECSP099395A (es) Nuevos derivados de los ácidos amino-nicotínico y amino-isonicotínico
CU23926B1 (es) Derivado de oxopirazina y herbicida
AR052568A1 (es) Derivados de pirazolo -pirimidina como antagonstas de mglur2
CY1109911T1 (el) Πυρρολοβενζοδιαζεπινες
ECSP10010368A (es) Derivados de urea de tetrahidroquinoxalina, su preparación
CO6150142A2 (es) Bezoxazoles y oxazolopiridinas que son utiles como inhibidores de las cinasas janus
CO5700820A2 (es) Derivados de dioxan-2-alquilcarbamatos, su preparacion y su aplicacion en terapeutica
CO6251235A2 (es) Compuestos derivados de azetidinas su preparacion y su aplicacion en terapeutica
BRPI0606480A (pt) compostos farmacêuticos
AR055635A1 (es) Uso de sulfonanilidas como herbicidas
GT200500286A (es) Analogos de anilino-pirimidina
AR061548A1 (es) 3-aminopirrolidino-4-lactamas sustituidas como inhibidoras de dipeptidilpeptidasa iv (dpp-iv), composiciones farmaceuticas que las comprenden y el uso de las mismas en el tratamiento de la diabetes ii.
UY29742A1 (es) Procedimiento para la preparación de betamimeticos
CR9375A (es) Derivados de ciclopropanocarboxamida
EA200800701A1 (ru) 4-замещенные пирролидин-2-оны и их применение
ECSP088194A (es) Antagonistas de cgrp seleccionados, procedimientos para su preparación, así como su uso como medicamentos
EA200801365A1 (ru) Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины
CO6321168A2 (es) Nuevos derivados de 2-amidotiadiazol
ES2557477T3 (es) Nuevos compuestos peptídicos cíclicos
UY29070A1 (es) Enantiómeros de heterocíclicos fusionados y sus usos
AR044342A1 (es) Derivados de bencimidazol
UY30009A1 (es) Compuestos benzoilpirazol y herbicidas que los contienen
CO6341610A2 (es) Compuesto heterociclilo aromatico que contiene nitrogeno.
AR073043A1 (es) Compuestos de azetidinas polisustituidos, composiciones farmaceuticas que los contienen, metodo de preparacion y uso de los mismos en el tratamiento de enfermedades respiratorias, metabolicas y del sistema nervioso central, entre otras.

Legal Events

Date Code Title Description
FB Suspension of granting procedure